HPV vaccine delivery with childhood shots
Treatments studied
Part of Infections clinical trials.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy child between 9 months and 5 years old, or an unmarried female between 15 and 20 years old.
- If you’re a child, be up to date on routine childhood vaccines (like polio, measles).
- Live in the study area and plan to stay for the whole study.
- Be HIV-negative (or if you’re a baby, your mom needs to have tested negative during pregnancy).
- If you’re a young female, not be pregnant and use birth control during the study (unless you’re a child where this doesn’t apply).
- Not have had the HPV vaccine before (for the older female group).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a single dose of the HPV vaccine (Gardasil 9) can lower the amount of HPV virus in women who already have the virus, potentially reducing how easily it spreads. It will help us learn if vaccination can protect partners and communities.
This trial tests if a single dose of a locally made HPV vaccine (CERVAVAC) works as well as a single dose of the standard Gardasil vaccine. It is for girls and young women aged 9 to 20, and boys aged 9 to 14, in Zambia. The goal is to prevent HPV infection, which can cause cervical cancer.
This study combines HPV vaccination with other health services for young people in Ivory Coast. It aims to protect adolescents against HPV, which can cause cancer, while also checking their overall health and well-being.
This study is interviewing girls ages 9 to 14 and their caregivers in Ethiopia to learn how to better integrate HPV vaccination into routine health services. If you received an HPV vaccine or other VYA service on the day you were recruited, you may be able to share your experience.
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
This study tests giving the HPV vaccine along with HPV screening to quickly reduce HPV infection and cervical cancer. It is for women aged 23-29 in Rwanda who choose to join.
Hear when a new HPV Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.